Navigation Links
Big Pharma Dealmaking Activity Highlighted by CurrentPartnering in Comprehensive Report Published at MarketPublishers.com
Date:9/9/2013

London, UK (PRWEB) September 09, 2013

What are the leading big pharma companies? What does the company’s recent dealmaking activity look like? What are the key terms included in a partnering agreement? What are the key aspects of partnering? What are the predominant big pharma companies’ dealmaking trends over the last four years? How to assess a prospective partner’s flexibility? How to submit an opportunity to big pharma? How to determine under what terms a prospective partner agrees to a partnering relationship? How does the negotiation process look like? What are the key issues and aspects of the dealmaking? What is actually granted by the agreement to the partner company? How are disputes during the dealmaking process resolved? Which jurisdiction does the company insist upon for agreement law? The answers to all these questions and other essential information required to better understand big pharma partnering ?an be found in the report.

Comprehensive research report “Partnering Deals and Alliances with Big Pharma” worked out by CurrentPartnering has been recently published by Market Publishers Ltd.

Report Details:

Title: Partnering Deals and Alliances with Big Pharma
Published: July, 2013
Pages: 877
Price: US$ 2,995.00
http://marketpublishers.com/report/life_sciences/pharmaceuticals/partnering-deals-n-alliances-with-big-pharma.html

The report offers in-depth insights into the dealmaking interests and activity of the world’s top fifty big pharma companies by providing their comprehensive partnering activity profiles. It presents essential data on each of the companies’ partnering activities since 2007; presents a full listing of partnering deals by deal type, industry sector, phase of development, technology type and therapeutic area; grants comprehensive access to over 3,000 partnering deals together with contract documents if available. The research contains gives objective insights into the terms included in a partnering agreement, with real world clause examples; uncovers details on the forthcoming big pharma partnering events, and evaluates the big pharma future opportunities.

Reasons to Buy:

  • The report provides a reader with an in-depth understanding of the partnering activities of the leading fifty big pharma companies worldwide.
  • Comprehensive dealmaking profiles of the companies enable to understand the key aspects of the partnering deals and to prepare for making a successful contract.
  • The study helps to undertake the key deal terms as well as due diligence to assess suitability of proposed deal terms for partner companies.
  • Review of the company’s dealmaking activity during 2007-2013 assist in assessing and choosing the potential business partners.

More in-demand research studies by CurrentPartnering can be found at http://marketpublishers.com/members/currentpartner/info.html

About Us:

MarketPublishers.com is a multilingual hypermarket offering a rich collection of comprehensive studies on various markets, sectors, industries, companies, etc. We perform professional services aimed to equip our clients with high-quality research products and support critical decision-making.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11102860.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Lawsuit Alleges Takeda Pharmaceutical Co., Maker of Diabetes Drug Actos, Didn’t Warn of the Drug’s Risks Soon Enough; Parker Waichman LLP Responds
2. Targeted Medical Pharma Initiates Clinical Trial of Red Blood Cell Stimulating Formulation
3. Global Pharmaceutical Packaging Market is Expected to Reach USD 73.04 Billion in 2018: Transparency Market Research
4. 67 Pharmaceutical Markets with 2013 Facts & Figures Reviewed in New Research Report at ReportsnReports.com
5. Pathways Pharmacist Denise Schoenberger Honored for Healthcare Excellence by Silicon Valley Business Journal
6. Drug Delivery Technology Pharmaceutical Market (Metered Dose Inhalers, Needle-Free Injectors) is Worth $224.2 Billion by 2017 - New Report by MarketsandMarkets
7. Leiter's Compounding Pharmacy Welcomes New Director of Marketing
8. World Radiopharmaceuticals Market to Reach USD 5.5bn in 2017, According to M&M Report Available at MarketPublishers.com
9. Phen375 Released The Newest Pharmacy-Grade Rapid Weight Loss Supplement
10. Could You Have Sleep Apnea? - Consumer Wellness Tips from Ritch's Pharmacy and HealthMart
11. Pharmaceutical Excipients Market Demand was 519.5 Kilo Tons in 2011 And is Expected to Reach 685.6 Kilo Tons in 2018 : Transparency Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris F. ... AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking place ... the field of medical informatics, this prestigious award is presented to an individual whose ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/19/2017)... ANN ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical ... the precise destruction of targeted tissues, announced three leadership team developments today:   ... Josh Stopek, PhD ... ... Veteran medical device executive ...
(Date:9/13/2017)... , Sept. 13, 2017   OrthoAtlanta has ... the Atlanta Football Host Committee (AFHC) for the 2018 College ... Jan. 8, 2018, at Mercedes-Benz Stadium in Atlanta, ... of the AFHC "I,m In" campaign, participating in many activities ... ...
Breaking Medicine Technology: